Benefits of LumiBio in an NHS setting
… a summary
Rising pressure in the NHS
NHS England has recently published the latest figures detailing waiting times for routine operations and diagnostic investigations for patients. These figures show there were 4.5 million people waiting for routine operations, of those almost 200,000 had been on the waiting list for more than a year. It also shows that 330,000 people are waiting more than six weeks for key diagnostic investigations.
Contributions to the pressure in the NHS system during the pandemic include;
Admissions and pressure on critical beds
Cancellation of routine operations due to lack of bed capacity
Shortage of staff due to sick leave resulting in lack of capacity
Downtime in health facilities due additional deep clean requirements, along with the need to ventilate some clinical areas to reduce infection risk to patients
Treatments postponed due to patients risk of infection, for example the elderly or clinically vulnerable
Patients own choice to postpone treatment due to fear of risk of infection
Vaccine roll out
Staff sickness and absence due to Covid infection
How can LumiBio benefit the NHS at this critical time?
LumiBio was developed specifically to support Health and Social care providers to achieve and maintain clean, safe, and infection-controlled environments. LumiBio provides an advanced, safe, all-encompassing infection control system that integrates seamlessly into existing IPC methods and cleaning regimes.
LumiBio is completely harmless, it does not have any adverse effect on staff, patients, the environment, or equipment. It is PH neutral and does not contain any bleach, bleaching agents, no UV light and does not produce any harmful gas. It is not a ‘fogging’ system, it is not administered by anyone wearing a PPE.
What it is, is a system that will work in live environments (meaning no downtime) unobtrusively and silently protecting staff and patients and the facility they are in.
Without doubt the NHS system is going above and beyond to battle this pandemic. Adopting increased traditional methods of Infection, Prevention and Control, that are known to reduce infection risk to lower levels.
Sadly, as described above these measures place additional burdens on an already stretched system and alone are not enough to protect staff and patients completely and confidently in these environments.
The benefits of adopting LumiBio in an NHS setting has numerous positive impacts on the current situation and beyond. LumiBio provides:
A way to significantly reduce the risk of infection in NHS settings for staff and patients
An IPC method that is completely safe monitored, and evidence backed
An advanced IPC method that does not burden staff with additional tasks
A cost-effective IPC method that has been independently tested, verified and proven effective against a wide range of pathogens including Sars-COV-2
A way to reassure staff and patients that healthcare settings are safe places be
